Stephen H. Leech

434 total citations
29 papers, 326 citations indexed

About

Stephen H. Leech is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Stephen H. Leech has authored 29 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Stephen H. Leech's work include Renal Transplantation Outcomes and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Complement system in diseases (3 papers). Stephen H. Leech is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Complement system in diseases (3 papers). Stephen H. Leech collaborates with scholars based in United States, France and Egypt. Stephen H. Leech's co-authors include Christopher Bryan, Prem Kumar, Brian E. Bozelka, Robert L. Marier, Robert C. Elston, David J. Karras, Katherine L. Heilpern, Nathan I. Shapiro, Sharon Rubin and Bruce Goldman and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Stephen H. Leech

27 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen H. Leech United States 12 92 60 54 51 35 29 326
Malin Lindqvist Sweden 8 102 1.1× 100 1.7× 34 0.6× 48 0.9× 47 1.3× 9 424
Touraine Jl France 11 37 0.4× 45 0.8× 110 2.0× 94 1.8× 30 0.9× 81 395
Nicolas Ferrari France 6 161 1.8× 112 1.9× 60 1.1× 42 0.8× 14 0.4× 10 630
Mary R. Rolfs United States 10 145 1.6× 17 0.3× 67 1.2× 104 2.0× 17 0.5× 15 377
M Foulard France 10 73 0.8× 60 1.0× 69 1.3× 85 1.7× 7 0.2× 20 401
Harald E. Fischer United States 11 185 2.0× 37 0.6× 76 1.4× 63 1.2× 8 0.2× 21 435
Magdalene Vas Canada 6 64 0.7× 64 1.1× 60 1.1× 265 5.2× 11 0.3× 9 542
H. C. van Prooijen Netherlands 13 302 3.3× 47 0.8× 23 0.4× 40 0.8× 12 0.3× 25 483
Ismet Aydogdu Türkiye 11 93 1.0× 46 0.8× 40 0.7× 74 1.5× 24 0.7× 27 370
Michihito Okubo Japan 14 16 0.2× 98 1.6× 84 1.6× 107 2.1× 28 0.8× 46 463

Countries citing papers authored by Stephen H. Leech

Since Specialization
Citations

This map shows the geographic impact of Stephen H. Leech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen H. Leech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen H. Leech more than expected).

Fields of papers citing papers by Stephen H. Leech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen H. Leech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen H. Leech. The network helps show where Stephen H. Leech may publish in the future.

Co-authorship network of co-authors of Stephen H. Leech

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen H. Leech. A scholar is included among the top collaborators of Stephen H. Leech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen H. Leech. Stephen H. Leech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weekes, Anthony J., Jeremy S. Boyd, Jason T. Nomura, et al.. (2021). Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE). SHILAP Revista de lepidopterología.
2.
Lee, Iris, S Constantinescu, Avrum Gillespie, et al.. (2010). Targeting alloantibody production with bortezomib: does it make more sense?. PubMed. 397–403. 1 indexed citations
3.
Karachristos, Andreas, Nicole M. Sifontis, Justin Darrah, et al.. (2009). Outcomes of Renal Transplantation in Older High Risk Recipients: Is There an Age Effect?. Journal of Surgical Research. 161(2). 173–178. 11 indexed citations
4.
Zalata, Khaled, Wesam A. Nasif, Si‐Chun Ming, et al.. (2005). p53, Bcl‐2 and C‐Myc Expressions in Colorectal Carcinoma Associated with Schistosomiasis in Egypt. Analytical Cellular Pathology. 27(4). 245–253. 27 indexed citations
5.
Leech, Stephen H., Sharon Rubin, Howard J. Eisen, et al.. (2003). Cardiac transplantation across a positive prospective lymphocyte cross‐match in sensitized recipients. Clinical Transplantation. 17(s9). 17–26. 27 indexed citations
6.
Hejtmancik, J. Fielding, Susan H. Black, David H. Ledbetter, et al.. (1992). Congenital 21-hydroxylase deficiency as a new deletion mutation. Human Immunology. 35(4). 246–252. 8 indexed citations
7.
Bryan, Christopher, et al.. (1991). The Immune System in Hereditary Hemochromatosis: A Quantitative and Functional Assessment of the Cellular Arm. The American Journal of the Medical Sciences. 301(1). 55–61. 12 indexed citations
8.
Leech, Stephen H., Rebecca J. Brown, & Moses S. Schanfield. (1985). Genetic studies in multiple myeloma. II. Immunoglobulin allotype associations. Cancer. 55(7). 1473–1476. 7 indexed citations
9.
Hendrick, Alex, B J Gormus, & Stephen H. Leech. (1985). Comparison of peripheral blood lymphocyte C3 receptor capping properties in patients with chronic lymphocytic leukemia and lymphoma. Cancer. 56(7). 1538–1542. 1 indexed citations
10.
Kumar, Prem, Robert L. Marier, & Stephen H. Leech. (1984). Respiratory Allergies Related to Automobile Air Conditioners. New England Journal of Medicine. 311(25). 1619–1621. 19 indexed citations
11.
Bryan, Christopher, Stephen H. Leech, Corwin Q. Edwards, et al.. (1984). Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral blood. Journal of Clinical Immunology. 4(2). 134–142. 12 indexed citations
12.
Leech, Stephen H., Christopher Bryan, Robert C. Elston, et al.. (1983). Genetic studies in multiple myeloma 1. Association with HLA-Cw5. Cancer. 51(8). 1408–1411. 19 indexed citations
13.
Leech, Stephen H., et al.. (1982). Augmentation of the antibody response by hapten help. Cellular Immunology. 71(2). 315–325. 4 indexed citations
14.
Leech, Stephen H., et al.. (1982). Biological modification of hapten help. International Journal of Immunopharmacology. 4(4). 277–277. 1 indexed citations
15.
Gormus, B J, Michael L. Basara, Martin M. Oken, Stephen H. Leech, & Manuel E. Kaplan. (1981). Capping of peripheral blood lymphocyte C3 receptors in chronic lymphocytic leukemia: Relationship to chemotherapy. International Journal of Cancer. 27(2). 151–159. 3 indexed citations
16.
Leech, Stephen H., et al.. (1981). Low-dose restriction in Ir-gene control reflects susceptibility to tolerance induction. Cellular Immunology. 64(2). 350–358. 2 indexed citations
17.
Kluger, Jeffrey, et al.. (1981). Long-term antiarrhythmic therapy with acetylprocainamide. The American Journal of Cardiology. 48(6). 1124–1132. 21 indexed citations
18.
Leech, Stephen H.. (1980). Cellular Immunosenescence. Gerontology. 26(6). 330–345. 22 indexed citations
19.
Kumar, Prem, Dankward Kodlin, Charles Marks, & Stephen H. Leech. (1980). Predictive value of serum complement (C3) in renal allograft rejection. British journal of surgery. 67(7). 500–502. 7 indexed citations
20.
Leech, Stephen H., et al.. (1972). Chronic Hemodialysis in Myelomatosis. Annals of Internal Medicine. 77(2). 239–242. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026